塞费皮姆/恩梅塔扎巴克坦:首次获得批准
1Springer Nature, Private Bag 65901, Mairangi Bay, Auckland, 0754, New Zealand. dru@adis.com.
Drugs
|May 18, 2024
概括
一种IV抗菌剂Cefepime/enmetazobactam已获批准用于治疗多药耐药格拉姆阴性细菌感染. 这一里程碑为复杂的尿路感染和医院获得的肺炎提供了新的选择.
科学领域:
- 药理学 药理学是指药理学的学科.
- 传染性疾病 传染性疾病
- 药物开发 药物开发
背景情况:
- 多抗药性 (MDR) 格拉姆阴性细菌感染对全球健康构成重大威胁.
- 对于由扩展光谱β-乳酸酶 (ESBL) 生产细菌引起的感染,存在有限的治疗选择.
- 塞费皮姆 (Cefepime/enmetazobactam) 结合了第四代头素与ESBL抑制剂.
研究的目的:
- 要总结cefepime/enmetazobactam的发展里程碑.
- 突出美国和欧盟最近的监管批准.
- 提出塞费皮姆/恩米塔扎巴克坦作为一种新的治疗选择,用于对抗MDR格兰氏阴性病原体.
主要方法:
- 审查开发历史和监管提交的文件.
- 对临床试验数据的分析,以支持疗效和安全性 (细节未提供摘要).
- 已批准的指示和目标病原体的摘要.
主要成果:
- 在2024年2月,Cefepime/enmetazobactam获得了美国FDA的批准,用于复杂的尿路感染 (cUTI).
- 欧洲药物署 (EMA) 在2024年3月的批准涵盖了cUTI,医院获得的肺炎 (HAP) 和呼吸机相关的肺炎 (VAP).
- 已被批准用于关键格拉姆阴性细菌的敏感菌株,包括大肠杆菌,肺炎,P. aeruginosa.
结论:
- 塞费皮姆 (Cefepime/enmetazobactam) 代表了治疗MDR格兰氏阴性细菌感染的重大进展.
- 主要市场的监管批准为临床医生提供了一种新的静脉注射治疗选择.
- 进一步的临床数据将继续定义cefepime/enmetazobactam在对抗耐药性感染中的作用.
更多相关视频
相关概念视频
01:26FDA Approved Drugs: Changes to Approved Drugs
Post-approval, manufacturers may modify an approved new or generic drug product. Such modifications can encompass alterations in the Active Pharmaceutical Ingredient (API), manufacturing process, formulation, batch size, manufacturing site, and container closure system (FDA Guidance for Industry, April 2004). Often, a drug product may undergo multiple changes.These modifications require careful evaluation to determine their potential impact on the drug product's identity, strength, quality,...
01:15Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure (CHF).
01:28Acute Pyelonephritis II: Diagnostic Studies and Management
Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
01:25Mechanism of Antibiotic Resistance in MRSA
Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
01:23Inhibitors of Gram-positive Cell Wall Synthesis
Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
01:25Clinical Significance of Antibiotic Resistance
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...